Skip to main content

Recent Decade Saw No Change in Diabetes Prevalence in U.S. Adults

Medically reviewed by Carmen Pope, BPharm. Last updated on March 7, 2025.

By Elana Gotkine HealthDay Reporter

FRIDAY, March 7, 2025 -- Between 2013 and 2023, there was no change in the prevalence of diabetes among U.S. adults, but glycemic control worsened, according to a research letter published online Feb. 27 in the Journal of the American Medical Association.

Kosuke Inoue, M.D., Ph.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues examined trends in the prevalence and control of diabetes among U.S. adults aged 20 years or older between 2013 and 2023 using data from the National Health and Nutrition Examination Survey.

A total of 24,263 adults were included in the unweighted study population; 4,623 had diabetes. The researchers found no significant change in the prevalence of diabetes, from 12.8 percent in 2013-2014 to 14.1 percent in 2021-2023. Among adults with a diagnosis of diabetes, mean hemoglobin A1c (HbA1c) levels were stable between 2013-2014 and 2017-2020, but they increased significantly from 2017-2020 to 2021-2023 (7.31 to 7.60 percent). Glycemic control rates were also stable between 2013-2014 and 2017-2020 but decreased from 2017-2020 to 2021-2023 (54.3 to 43.5 percent). Increases in mean HbA1c levels were mainly seen among young adults aged 20 to 44 years (7.43 to 8.51 percent), and they also had a significant decline in rates of glycemic control (57.4 to 37.1 percent). Across other age or sex subgroups, there were no similar patterns observed.

"Given the recent stagnation in mortality improvement among young adults with diabetes and the increased risk of adverse cardiovascular outcomes associated with poor glycemic control, public health and policy efforts are needed to improve diabetes control, especially in younger populations," the authors write.

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted March 2025

Read this next

Increasing Proportion of U.S. Adults Unaware They Have Hypertension

MONDAY, June 9, 2025 -- From 2013 to 2023, there was an increase in the proportion of U.S. adults who were unaware of having hypertension, according to a research letter published...

Finerenone + Empagliflozin Offers Greater Benefit in CKD, T2DM

MONDAY, June 9, 2025 -- For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater reduction in the urinary...

Concurrent Hypertension + Type 2 Diabetes Predict High Mortality Risk

WEDNESDAY, June 4, 2025 -- Adults with concurrent hypertension and type 2 diabetes (T2D) have high mortality risk compared with those who have neither condition or only one...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.